Skip to content
Screener

EPS (Diluted) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$12.23-4.5%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
-$1.09-28.2%
KLR
Kalaris TherapeuticsKLRS
-$0.46+81.7%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$1.01-17.4%
HRO
HarrowHROW
-$0.74-48.0%
PVL
Palvella TherapeuticsPVLA
-$1.20-62.2%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
General and administrative11,23015,429
Total operating expenses59,77759,073
Loss from operations(59,777)(59,073)
Interest income1,6411,602
Other income (expense), net(22)10
Net loss and comprehensive loss$(58,158)$(57,461)
Net loss per share, basic and diluted$(0.94)$(1.09)
Weighted-average shares outstanding, basic and diluted61,859,48552,746,318

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's EPS (diluted)?
Kodiak Sciences Inc (KOD) reported EPS (diluted) of -$0.94 in Q1 2026.
How has Kodiak Sciences Inc's EPS (diluted) changed year-over-year?
Kodiak Sciences Inc's EPS (diluted) increased by 13.8% year-over-year, from -$1.09 to -$0.94.
What is the long-term trend for Kodiak Sciences Inc's EPS (diluted)?
Over 4 years (2021 to 2025), Kodiak Sciences Inc's EPS (diluted) has grown at a -4.3% compound annual growth rate (CAGR), from -$5.15 to -$4.32.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Kodiak Sciences Inc's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude